Wolle Meraf A, Muñoz Beatriz E, Mkocha Harran, West Sheila K
Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Ophthalmology. 2009 Feb;116(2):243-7. doi: 10.1016/j.ophtha.2008.09.011. Epub 2008 Dec 16.
Clinically, constant severe trachoma predicts an increased risk of scarring in children. There are no data on the risk of scarring associated with constant infection with Chlamydia trachomatis, regardless of clinical manifestation. We propose to determine the 5-year incidence of scarring in children with a history of constant severe trachoma, constant infection, or both compared with children who had a history of neither.
A 5-year, longitudinal observational study.
Children aged less than 10 years with data on trachoma and infection for 3 of the 5 visits in the first 18 months, and follow-up 5-year data on scarring.
Data were collected on clinical trachoma, and ocular swabs were taken to determine the presence of C. trachomatis in children in a hyperendemic village in Tanzania. Images were graded for scarring. Data were collected at baseline; 2, 6, 12, and 18 months; and 5 years from baseline. Severe trachoma was defined as the presence of 10 or more follicles, or trachoma intense. A child had constant infection (severe trachoma) if infection (severe trachoma) was present on at least 3 visits before the 5-year survey.
Five-year risk of scarring.
Of the 189 children, 22 (11.6%) had constant severe trachoma, but not constant infection. Nine children (4.8%) had constant infection but not constant severe trachoma. Both constant severe trachoma and constant infection were present in 16 children (8.5%). The 5-year incidence of scarring was similar in all 3 groups; children with constant severe trachoma only, with constant infection only, and with both were most likely to develop scars (35.0%, 44.4%, 31.2%, respectively) compared with those with sporadic trachoma or infection (15.2%) or neither (6.8%) (P = 0.0002).
Children with constant infection are also likely to have constant severe trachoma, and their 5-year risk of scarring is high compared with children with sporadic severe trachoma or infection. These data further support the presence of a subgroup of children who cannot clear infection with C. trachomatis, who may manifest a severe immunologic response to infection, and who are at increased risk of scarring sequelae.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
临床上,持续性重度沙眼预示儿童瘢痕形成风险增加。目前尚无关于沙眼衣原体持续感染(无论临床表现如何)相关瘢痕形成风险的数据。我们拟确定有持续性重度沙眼病史、持续性感染病史或两者皆有的儿童与无上述病史的儿童相比,5年内瘢痕形成的发生率。
一项为期5年的纵向观察性研究。
年龄小于10岁的儿童,在前18个月的5次就诊中有3次有沙眼和感染数据,并有5年瘢痕形成的随访数据。
在坦桑尼亚一个沙眼高度流行的村庄收集儿童临床沙眼数据,并采集眼拭子以确定沙眼衣原体的存在。对图像进行瘢痕分级。在基线、2、6、12和18个月以及基线后5年收集数据。重度沙眼定义为存在10个或更多滤泡或沙眼炎症。如果在5年调查前至少3次就诊时存在感染(重度沙眼),则该儿童有持续性感染(重度沙眼)。
5年内瘢痕形成风险。
189名儿童中,22名(11.6%)有持续性重度沙眼,但无持续性感染。9名儿童(4.8%)有持续性感染但无持续性重度沙眼。16名儿童(8.5%)同时存在持续性重度沙眼和持续性感染。所有3组儿童5年内瘢痕形成发生率相似;与偶发性沙眼或感染(15.2%)或两者皆无(6.8%)的儿童相比,仅患有持续性重度沙眼、仅患有持续性感染以及两者皆有的儿童最易形成瘢痕(分别为35.0%、44.4%、31.2%)(P = 0.0002)。
持续性感染的儿童也可能患有持续性重度沙眼,与偶发性重度沙眼或感染的儿童相比,其5年内瘢痕形成风险较高。这些数据进一步支持存在一组无法清除沙眼衣原体感染的儿童,他们可能对感染表现出严重的免疫反应,并且瘢痕形成后遗症风险增加。
专有或商业披露信息可在参考文献之后找到。